ベインのウェブサイトは、ユーザーの、利便性の向上、と機能改善のために、クッキーを使用しています。詳細は、弊社のプライバシーポリシーをご参照ください。このサイト閲覧を継続されることで、クッキーの使用についてご了承いただいたことになります。

ケーススタディ

Pharma oncology growth strategy

A leading player in the oncology market was seeking to grow in the face of increasing competition, regulation and other pressures. Bain created a framework to help the pharmaceutical company optimize its portfolio to support the company's revenue goals, and developed a plan for the company to close the revenue gap by making the most of its existing investments.

  • min read

全文

The Situation

  • Pharma Co.* is a leading player in the oncology market and wants to grow and retain its competitive position
  • Oncology market is growing, but is increasingly competitive and increasingly impacted by payers/regulators
  • Pharma Co.'s current portfolio does not support revenue goals within oncology
  • Project prioritization is complex due to uncertainty of compounds having multiple indications
  • Existing process and tools are not effective for making strategic trade-offs for single compounds and entire portfolio

Our Approach

Improve the NPD process:

The Recommendations

Develop a framework to optimize portfolio decisions:

The Results

Plan developed to close the revenue gap:

 

* We take our clients' confidentiality seriously. While we've changed their names, the results are real. 

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。